Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 9.92% is 115% above its 5-year average of 4.61%, near the high end of its 5-year range (-174.69%–28.98%).
119.18% above its 12-month average of -51.72%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -116.54%.
OPERATING MARGIN
9.92%
OPERATING MARGIN AVG TTM
-51.72%
OPERATING MARGIN AVG 3Y
2.10%
OPERATING MARGIN AVG 5Y
4.61%
OPERATING MARGIN AVG 10Y
1.07%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+119.18%
CURRENT VS 3Y AVG
+372.11%
CURRENT VS 5Y AVG
+115.36%
CURRENT VS 10Y AVG
+826.86%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Organogenesis Holdings Inc.
Market Cap
$172.42M
Operating Margin
9.92%
TTM Avg
-51.72%
3Y Avg
2.10%
5Y Avg
4.61%
Market Cap
$171.13M
Operating Margin
-152.19%
TTM Avg
-95.13%
3Y Avg
-132.07%
5Y Avg
-169.10%
Market Cap
$173.76M
Operating Margin
-275.91%
TTM Avg
-218.55%
3Y Avg
-684.79%
5Y Avg
-1856.99%
Market Cap
$174.27M
Operating Margin
-5219.12%
TTM Avg
-6964.55%
3Y Avg
-7004.82%
5Y Avg
-5165.96%
Market Cap
$169.53M
Operating Margin
-13.21%
TTM Avg
-18.79%
3Y Avg
-19.38%
5Y Avg
-19.19%
Market Cap
$168.92M
Operating Margin
-149.06%
TTM Avg
-122.45%
3Y Avg
-89.19%
5Y Avg
-74.10%
Market Cap
$168.10M
Operating Margin
-96.56%
TTM Avg
-271.71%
3Y Avg
-1442.10%
5Y Avg
-1248.16%
Market Cap
$179.26M
Operating Margin
-754.40%
TTM Avg
-377.20%
3Y Avg
-858.29%
5Y Avg
-865.86%
Market Cap
$165.32M
Operating Margin
11.45%
TTM Avg
-1.93%
3Y Avg
-15.11%
5Y Avg
-10.80%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Organogenesis Holdings Inc. (ORGO) | $172.42M | 9.92% | -51.72% | 2.10% | 4.61% |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | -152.19% | -95.13% | -132.07% | -169.10% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | -275.91% | -218.55% | -684.79% | -1856.99% |
| Yarrow Bioscience Inc (YARW)vs › | $174.27M | -5219.12% | -6964.55% | -7004.82% | -5165.96% |
| Journey Medical Corporation (DERM)vs › | $169.53M | -13.21% | -18.79% | -19.38% | -19.19% |
| MediWound Ltd. (MDWD)vs › | $168.92M | -149.06% | -122.45% | -89.19% | -74.10% |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | -96.56% | -271.71% | -1442.10% | -1248.16% |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $179.26M | -754.40% | -377.20% | -858.29% | -865.86% |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 11.45% | -1.93% | -15.11% | -10.80% |
| Nkarta, Inc. (NKTX)vs › | $165.27M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
67.6%
Operating Margin
9.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -116.54% |
| 2026-03-31 | -174.69% |
| 2025-12-31 | 28.98% |
| 2025-09-30 | 14.39% |
| 2025-06-30 | -10.75% |
| 2025-03-31 | -23.28% |
| 2024-12-31 | 8.07% |
| 2024-09-30 | 5.42% |
| 2024-06-30 | -10.67% |
| 2024-03-31 | -3.50% |
| 2023-12-31 | -1.27% |
| 2023-09-30 | 7.42% |
| 2023-06-30 | 8.31% |
| 2023-03-31 | -3.72% |
| 2022-12-31 | 7.55% |
| 2022-09-30 | 1.52% |
| 2022-06-30 | 9.83% |
| 2022-03-31 | -0.13% |
| 2021-12-31 | 15.91% |
| 2021-09-30 | 14.30% |
| 2021-06-30 | 19.15% |
| 2021-03-31 | 12.30% |
| 2020-12-31 | 20.38% |
| 2020-09-30 | 22.62% |
| 2020-06-30 | -3.27% |
| 2020-03-31 | -24.43% |
| 2019-12-31 | -2.35% |
| 2019-09-30 | -12.86% |
| 2019-06-30 | -11.27% |
| 2019-03-31 | -21.22% |
| 2018-12-31 | -7.04% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | -19.71% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 291.66% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
